Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Galectin Therapeutics Inc (NASDAQ: GALT) was $4.03 for the day, down -7.99% from the previous closing price of $4.38. In other words, the price has decreased by -$7.99 from its previous closing price. On the day, 0.95 million shares were traded. GALT stock price reached its highest trading level at $4.4186 during the session, while it also had its lowest trading level at $3.96.
Ratios:
Our analysis of GALT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.09 and its Current Ratio is at 0.09.
On August 13, 2020, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $9 to $12.
On February 13, 2019, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $11.B. Riley FBR initiated its Buy rating on February 13, 2019, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 17 ’25 when LEWIS JOEL sold 7,829 shares for $7.06 per share. The transaction valued at 55,241 led to the insider holds 832,592 shares of the business.
Jamil Khurram sold 19,442 shares of GALT for $136,872 on Dec 17 ’25. The Chief Medical Officer now owns 0 shares after completing the transaction at $7.04 per share. On Dec 17 ’25, another insider, Shlevin Harold H., who serves as the Director of the company, sold 24,499 shares for $7.04 each. As a result, the insider received 172,424 and left with 6,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GALT now has a Market Capitalization of 259851216 and an Enterprise Value of 376567360.
Stock Price History:
The Beta on a monthly basis for GALT is 1.04, which has changed by 4.214286 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, GALT has reached a high of $7.13, while it has fallen to a 52-week low of $0.73. The 50-Day Moving Average of the stock is -27.10%, while the 200-Day Moving Average is calculated to be 19.98%.
Shares Statistics:
GALT traded an average of 451.77K shares per day over the past three months and 1046130 shares per day over the past ten days. A total of 64.47M shares are outstanding, with a floating share count of 45.96M. Insiders hold about 28.73% of the company’s shares, while institutions hold 15.94% stake in the company. Shares short for GALT as of 1764288000 were 6816789 with a Short Ratio of 15.09, compared to 1761868800 on 6903772. Therefore, it implies a Short% of Shares Outstanding of 6816789 and a Short% of Float of 14.97.
Earnings Estimates
A comprehensive evaluation of Galectin Therapeutics Inc (GALT) is underway, with the input of 1.0 analysts contributing to its current rating.
Analysts are recommending an EPS of between -$0.49 and -$0.49 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$0.41, with 1.0 analysts recommending between -$0.41 and -$0.41.
